PharmiWeb.com - Global Pharma News & Resources
03-Jul-2019

Pharmacovigilance Outsourcing Market Size Poised to Touch USD 7 Billion by 2026

The Global Pharmacovigilance Outsourcing Market Size is expected to reach USD 7 Billion by 2026 and growing CAGR around 16 % during the forecast period 2018 to 2026.

The Global Pharmacovigilance Outsourcing Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1094

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Pharmacovigilance Outsourcing Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Pharmacovigilance Outsourcing Market?
  • What is the market drivers, restrains, opportunities governing the global Pharmacovigilance Outsourcing Market?
  • Which is the largest and the fastest growing segments in the global Pharmacovigilance Outsourcing Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Pharmacovigilance Outsourcing Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

The major players associated with the Pharmacovigilance Outsourcing Market are Bioclinica, Clintec, Covance, Medpace Holdings, Oracle Corporation, iGATE Corporation, Accenture, iMED Global Corporation, Symogen, Ergomed, IBM Corporation, IQVIA, MarksMan Healthcare, Parexel, SIRO Clinpharm and Novartis.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1094

The Major Market Segments of GlobalPharmacovigilance Outsourcing Marketare as below:

Market Segmentation

Market, By Service

  • Pre-marketing services
    • Clinical pharmacovigilance services
    • Case processing services
    • Safety data management services
    • Medical review
  • Post-marketing services
    • Knowledge process outsourcing services
    • IT solutions and services
  • Others

Market, By Service Provider

  • Contract research organizations (CROs)
  • Business process outsourcing (BPOs)

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026offers a detailed insights on global pharmacovigilance outsourcing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global pharmacovigilance outsourcing market by service, service providers, fuel, distribution channel and major geographic regions. The report also covers basic drug development policies.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Pharmacovigilance Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmacovigilance Outsourcing Market By Service
1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
1.2.2.3. Pre-marketing services
1.2.2.4. Post-marketing services
1.2.2.5. Others
1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
1.2.3.3. Contract research organizations (CROs)
1.2.3.4. Business process outsourcing (BPOs)
1.2.3.5. Others
1.2.4. Pharmacovigilance Outsourcing Market by Geography
1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017

CHAPTER 4. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE

4.1. Global Pharmacovigilance Outsourcing Revenue By Service
4.2. Pre-marketing services
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Post-marketing services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE PROVIDER

5.1. Global Pharmacovigilance Outsourcing Revenue By Service Provider
5.2. Contract research organizations (CROs)
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Business process outsourcing (BPOs)
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

6.1. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

7.1. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

9.1. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

10.1. Middle East Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

11.1. Africa Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Bioclinica
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Clintec
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Covance
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medpace Holdings
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Oracle Corporation
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. iGATE Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Accenture
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. iMED Global Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Symogen
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ergomed
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. IBM Corporation
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. IQVIA
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. MarksMan Healthcare
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Parexel
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. SIRO Clinpharm
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Novartis
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies
12.17. Others
12.17.1. Company Snapshot
12.17.2. Overview
12.17.3. Financial Overview
12.17.4. Product Portfolio
12.17.5. Key Developments
12.17.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1094

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 03-Jul-2019